High mammographic density in women is associated with protumor inflammation

Breast Cancer Res. 2018 Aug 9;20(1):92. doi: 10.1186/s13058-018-1010-2.

Abstract

Background: Epidemiological studies have consistently shown that increased mammographic density (MD) is a strong risk factor for breast cancer. We previously observed an elevated number of vimentin+/CD45+ leukocytes in high MD (HMD) epithelium. In the present study, we aimed to investigate the subtypes of immune cell infiltrates in HMD and low MD (LMD) breast tissue.

Methods: Fifty-four women undergoing prophylactic mastectomy at Peter MacCallum Cancer Centre or St. Vincent's Hospital were enrolled. Upon completion of mastectomy, HMD and LMD areas were resected under radiological guidance in collaboration with BreastScreen Victoria and were subsequently fixed, processed, and sectioned. Fifteen paired HMD and LMD specimens were further selected according to their fibroglandular characteristics (reasonable amount [> 20%] of tissue per block on H&E stains) for subsequent IHC analysis of immune cell infiltration.

Results: Overall, immune cell infiltrates were predominantly present in breast ducts and lobules rather than in the stroma, with CD68+ macrophages and CD20+ B lymphocytes also surrounding the vasculature. Macrophages, dendritic cells (DCs), B lymphocytes, and programmed cell death protein 1 (PD-1) expression were significantly increased in HMD epithelium compared with LMD. Moreover, significantly higher levels of DCs, CD4+ T cells, and PD-1 were also observed in HMD stroma than in LMD stroma. The increased expression of interleukin (IL)-6 and IL-4, with unaltered interferon-γ, indicate a proinflammatory microenvironment.

Conclusions: Our work indicates that the immune system may be activated very early in breast cancer development and may in part underpin the breast cancer risk associated with HMD.

Keywords: B cells; Biomarker; Dendritic cells; Immune infiltration; Immunotherapy; Macrophages; Mammographic density; PD-L1; T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Breast / diagnostic imaging
  • Breast / immunology
  • Breast / pathology*
  • Breast / surgery
  • Breast Density*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Cohort Studies
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Epithelium / immunology
  • Epithelium / pathology
  • Female
  • Humans
  • Inflammation / diagnostic imaging
  • Inflammation / immunology*
  • Inflammation / pathology
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mammography
  • Middle Aged
  • Mutation
  • PTEN Phosphohydrolase / genetics
  • Programmed Cell Death 1 Receptor / immunology
  • Programmed Cell Death 1 Receptor / metabolism
  • Prophylactic Mastectomy

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • PTEN Phosphohydrolase
  • PTEN protein, human